Genetic markers predicting final non-remission after 12 weeks of antidepressant treatment in patients exhibiting poor early improvement at 2 weeks were found using the WES data from a naturalistically treated depression cohort—the well-known COMT gene and 10 novel genes associated with neural functions, including neuronal maintenance and neural transmission. This evidence concerns the gene COMT and depressive symptom measurement.